Attachment 8 - PHS Human Subjects and Clinical Trials Info (Study Record Form).pdf

PDF 183 KB Posted

Attached to
Strong Heart Study (SHS) - Legacy Cohort FC
Solicitation number
75N92026R00011
Issued by

About this file

This document is a PHS Human Subjects and Clinical Trials Information form (OMB Number: 0925-0001, Expiration Date: 01/31/2026) used to register and report on human subjects research studies, particularly clinical trials conducted under federal oversight.

The form is structured across five major sections: Basic Information, Study Population Characteristics, Protection and Monitoring Plans, Protocol Synopsis, and Other Clinical Trial-related Attachments. Section 1 requires entry of a unique study title, exemption status determination, and completion of a Clinical Trial Questionnaire that assesses whether research meets the federal definition of a clinical trial based on four criteria—involvement of human participants, prospective assignment to interventions, evaluation of intervention effects, and health-related biomedical or behavioral outcomes. Section 2 collects demographic and enrollment data including study conditions, eligibility criteria, age limits, inclusion of women and minorities, recruitment status, and planned enrollment by racial and ethnic categories. Section 3 addresses human subjects protections, multi-site protocols, data and safety monitoring plans, and Data and Safety Monitoring Board appointment. Section 4 provides detailed protocol information including study design, primary purpose, intervention types and descriptions, study phase, intervention model, masking methodology, outcome measures with time frames, statistical design, subject participation duration, FDA-regulated intervention status, FDAAA applicability, and dissemination plans. Section 5 accommodates supplemental clinical trial-related attachments. The form also includes an Inclusion Enrollment Report subsection requiring title, dataset usage confirmation, enrollment location designation (domestic or foreign), specific locations, and enrollment demographics broken down by racial and ethnic categories with gender stratification. All data fields shown in the template are blank with zero values in demographic tables, indicating this is a blank form ready for completion by researchers.

View the file

Other files

Show all 13

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

* Always required field

Study Record: PHS Human Subjects and Clinical Trials Information OMB Number: 0925-0001

Expiration Date: 01/31/2026

Section 1 - Basic Information

1.1. * Study Title (each study title must be unique)

1.2. * Is this Study Exempt from Federal Regulations?

1.3. Exemption Number

1 2 3 4 5 6 7 8

1.4. * Clinical Trial Questionnaire

If the answers to all four questions below are yes, this study meets the definition of a Clinical Trial.

1.4.a. Does the study involve human participants? Yes No 1.4.b. Are the participants prospectively assigned to an intervention? Yes No

1.4.c. Is the study designed to evaluate the effect of the intervention on the participants? Yes No 1.4.d. Is the effect that will be evaluated a health-related biomedical or behavioral outcome? Yes No

1.5. Provide the ClinicalTrials.gov Identifier (e.g., NCT87654321) for this trial, if applicable

Section 2 - Study Population Characteristics

2.1. Conditions or Focus of Study

2.2. Eligibility Criteria

2.3. Age Limits Minimum Age Maximum Age

2.3.a. Inclusion of Individuals Across the Lifespan

2.4. Inclusion of Women and Minorities

2.5. Recruitment and Retention Plan

2.6. Recruitment Status

2.7. Study Timeline

2.8. Enrollment of First Participant

2.9. Inclusion Enrollment Report(s)

Yes No

View Attachment Add Attachment Delete Attachment

View Attachment Add Attachment Delete Attachment

View Attachment Add Attachment Delete Attachment

View Attachment Add Attachment Delete Attachment x Add New Condition

Add Inclusion Enrollment Report

Inclusion Enrollment Report

OMB Number: 0925-0770 Expiration Date: 09/30/2024

1. * Inclusion Enrollment Report Title

2. * Using an Existing Dataset or Resource

3. * Enrollment Location Type

4. Enrollment Country(ies)

5. Enrollment Location(s)

6. Comments

Remove Inclusion Enrollment Report

Yes No

Domestic Foreign x Add New Country

Planned

Racial Categories

Ethnic Categories Not Hispanic or Latino Hispanic or Latino Total

Female Male Female Male

American Indian/ Alaska Native

Asian

Native Hawaiian or Other Pacific Islander

Black or African American

White

More than One Race

Total

Cumulative (Actual)

Racial Categories

Ethnic Categories Not Hispanic or Latino Hispanic or Latino Unknown/Not Reported Ethnicity Total

Female

Male

Unknown/ Not

Reported

American Indian/ Alaska Native

Asian

Native Hawaiian or Other Pacific Islander

Black or African American

White

More than One Race

Unknown or Not

Total

Report 1 of 1

< Previous Report Next Report >

|<< First Report Delete Report Last Report >>|

Section 3 - Protection and Monitoring Plans

3.1. Protection of Human Subjects

3.2. Is this a multi-site study that will use the same protocol to conduct non-exempt human subjects research at more than one domestic site?

Yes No N/A

4.1. Study Design

4.1.a. Detailed Description

4.1.b. Primary Purpose

4.1.c. Interventions x Intervention Type

Name

Description

4.1.d. Study Phase

Is this an NIH-defined Phase III clinical trial? Yes No

4.1.e. Intervention Model

4.1.f. Masking

Yes

Participant

No

Care Provider Investigator Outcomes Assessor

4.1.g. Allocation

Single IRB plan attachment Add Attachment Delete Attachment View Attachment

3.3. Data and Safety Monitoring Plan Add Attachment Delete Attachment View Attachment

3.4. Will a Data and Safety Monitoring Board be appointed for this study?

Yes No

3.5. Overall Structure of the Study Team Add Attachment Delete Attachment View Attachment

Section 4 - Protocol Synopsis

Add New Intervention

4.2. Outcome Measures

x Name

Type

Time Frame

Brief Description

4.3. Statistical Design and Power

4.4. Subject Participation Duration

4.5. Will the study use an FDA-regulated intervention? Yes No

4.5.a. If yes, describe the availability of Investigational Product (IP) and Investigational New Drug (IND)/Investigational Device Exemption (IDE) status

4.6. Is this an applicable clinical trial under FDAAA? Yes No

4.7. Dissemination Plan

Section 5 - Other Clinical Trial-related Attachments

5.1. Other Clinical Trial-related Attachments

View Attachment Add Attachment Delete Attachment

View Attachments Add Attachments Delete Attachments

Add New Outcome

File details come from the government source that posted it. Updated .